We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
““These data provide mechanistic support for an early effect of angiotensin receptor neprilysin inhibitors (ARNIs) on cardiac remodeling and clinical outcomes in HFrEF, and suggest a novel paradigm for investigating the hemodynamic effects of other pharmacologic agents in clinical practice.””
No takes yet. Share an insight, caveat, or question.
Desai et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: